These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1868269)

  • 1. Binding of serum osteocalcin to hydroxyapatite in Paget's disease of bone.
    Torres R; de la Piedra C; Rapado A
    Bone Miner; 1991 Jul; 14(1):55-65. PubMed ID: 1868269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteocalcin and bone remodelling in Paget's disease of bone, primary hyperparathyroidism, hypercalcaemia of malignancy and involutional osteoporosis.
    Torres R; de la Piedra C; Rapado A
    Scand J Clin Lab Invest; 1989 May; 49(3):279-85. PubMed ID: 2787049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum bone GLA-protein is not a sensitive marker of bone turnover in Paget's disease of bone.
    Delmas PD; Demiaux B; Malaval L; Chapuy MC; Meunier PJ
    Calcif Tissue Int; 1986 Jan; 38(1):60-1. PubMed ID: 3079654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between serum osteocalcin and 24,25-dihydroxyvitamin D levels in Paget's disease of bone.
    Castro-Errecaborde N; de la Piedra C; Rapado A; Alvarez-Arroyo MV; Torres R; Traba ML
    J Clin Endocrinol Metab; 1991 Feb; 72(2):462-6. PubMed ID: 1991815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal carboxylation of circulating osteocalcin (bone Gla-protein) in Paget's disease of bone.
    Merle B; Delmas PD
    Bone Miner; 1990 Nov; 11(2):237-45. PubMed ID: 2176559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical usefulness of serum tartrate-resistant acid phosphatase in Paget's disease of bone: correlation with other biochemical markers of bone remodelling.
    Torres R; de la Piedra C; Rapado A
    Calcif Tissue Int; 1991 Jul; 49(1):14-6. PubMed ID: 1893290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of serum osteocalcin with total and bone specific alkaline phosphatase and urinary hydroxyproline:creatinine ratio in patients with Paget's disease of bone.
    Kaddam IM; Iqbal SJ; Holland S; Wong M; Manning D
    Ann Clin Biochem; 1994 Jul; 31 ( Pt 4)():327-30. PubMed ID: 7979096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoreactive osteocalcin forms in conditioned media from human osteoblast culture and in sera from healthy adult control subjects and patients with bone pathologies.
    Diaz Diego EM; Nacher M; Rapado A; Serrano S; Bosch J; Aubia J; de la Piedra C
    Eur J Clin Invest; 1998 Jan; 28(1):48-58. PubMed ID: 9502187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Osteocalcin].
    Galli M; Caniggia M
    Minerva Med; 1984 Nov; 75(42):2489-501. PubMed ID: 6334818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of serum osteocalcin in Paget's disease of bone and its response to diphosphonate treatment.
    Coulton LA; Preston CJ; Couch M; Kanis JA
    Arthritis Rheum; 1988 Sep; 31(9):1142-7. PubMed ID: 3048274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone alkaline phosphatase in Paget's disease.
    Deftos LJ; Wolfert RL; Hill CS
    Horm Metab Res; 1991 Nov; 23(11):559-61. PubMed ID: 1816067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary gamma-carboxyglutamic acid and serum osteocalcin as bone markers: studies in osteoporosis and Paget's disease.
    Gundberg CM; Lian JB; Gallop PM; Steinberg JJ
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1221-5. PubMed ID: 6605357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Separation and purefied of calf osteocalcin, set up radioimmunoassay for osteocalcin].
    Kong Y; Meng X; Zhou X; Liu H; Liu S
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Aug; 19(4):257-62. PubMed ID: 10453563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BGP (osteocalcin, bone-Gla-protein) in involutional osteoporosis.
    Rapado A; de la Piedra C; Torres R
    Clin Rheumatol; 1989 Jun; 8 Suppl 2():30-4. PubMed ID: 2788062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum osteocalcin in Paget's disease of bone: basal concentrations and response to bisphosphonate treatment.
    Papapoulos SE; Frolich M; Mudde AH; Harinck HI; vd Berg H; Bijvoet OL
    J Clin Endocrinol Metab; 1987 Jul; 65(1):89-94. PubMed ID: 3495547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteocalcin and urinary hydroxyproline/creatinine ratio in the differential diagnosis of primary hyperparathyroidism and hypercalcaemia of malignancy.
    de la Piedra C; Toural V; Rapado A
    Scand J Clin Lab Invest; 1987 Oct; 47(6):587-92. PubMed ID: 3499657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum bone gamma carboxyglutamic acid-containing protein in primary hyperparathyroidism and in malignant hypercalcemia. Comparison with bone histomorphometry.
    Delmas PD; Demiaux B; Malaval L; Chapuy MC; Edouard C; Meunier PJ
    J Clin Invest; 1986 Mar; 77(3):985-91. PubMed ID: 3485113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in plasma bone GLA protein during treatment of bone disease.
    Deftos LJ; Parthemore JG; Price PA
    Calcif Tissue Int; 1982 Mar; 34(2):121-4. PubMed ID: 6805917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between biochemical markers of bone turnover and bone scintigraphic indices in assessment of Paget's disease activity.
    Alvarez L; Peris P; Pons F; Guañabens N; Herranz R; Monegal A; Bedini JL; Deulofeu R; Martínez de Osaba MJ; Muñoz-Gómez J; Ballesta AM
    Arthritis Rheum; 1997 Mar; 40(3):461-8. PubMed ID: 9082934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential gene expression in cultured osteoblasts and bone marrow stromal cells from patients with Paget's disease of bone.
    Naot D; Bava U; Matthews B; Callon KE; Gamble GD; Black M; Song S; Pitto RP; Cundy T; Cornish J; Reid IR
    J Bone Miner Res; 2007 Feb; 22(2):298-309. PubMed ID: 17129176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.